Tuesday, March 3, 2026

New drug to suppress allergies, asthma

Continue reading

November 25, 2016
BIG STORY

Melbourne, Nov 25:

An Australian Nobel Prize-winning scientist is developing a drug to counter allergies and asthma, a statement said on Friday.

(courtesy:www.iowatracs.us) (courtesy:www.iowatracs.us)

Still in its initial stage the the drug can be taken as tablets, capsules, liquids or powder, Xinhua news reported.

Barry Marshall, a microbiology professor from University of Western Australia, who won the Nobel Prize in Physiology in 2005 for stomach ulcer research, is working on the new drug.

The medication, named Immbalance, aims to suppress an overactive immune system.

"This actually arose from work we were doing on helicobacter, the stomach bug, for which Robin Warren and I won the Nobel Prize a few years ago," Marshall said on Friday.

"We've discovered the way it survives in your body is by suppressing the immune system so you can't get rid of it.

"I can't guarantee that it's going to cure allergy sufferers... we think this kind of thing will bring people who are hyper reactive... down into the normal range."

Marshall, who spent the last seven years developing the drug, said that it can be formulated as tablets, capsules, liquids or powder.

"Children could spread the powder on their cereal or put it in a drink and over the course of a few months could suppress their allergic response," he said in a UWA media release.

"We think it's going to be 100 percent safe. It won't remove your immune system; it will just take the edge off."

(IANS)

About the Author
Biswajeet Swain

Biswajeet Swain, the senior sub-editor, joined the Sambad Group in 2016. Earlier, he was working with the digital wing of a regional newspaper. He writes on several subjects, including spot news, human interest stories, weather news, administrative news, education news, and crime news.

728x90 Advertisement

You May Also Like


DISCLAIMER
All content on this website is the exclusive property of Eastern Media Limited. Any downloadable material, including but not limited to electronic or digital versions of the newspaper (e-paper) in any format, is provided solely for personal use. Unauthorized dissemination, distribution, circulation, or publication of any content or e-paper (whether in PDF or other formats) by any means, including on social media platforms, without prior authorization, permission, or license is strictly prohibited.